We conclude that the administration of a high dose of intravenous NAC seems to be a promising treatment for incipient liver failure in patients with liver disease caused by EPP.
We conclude that the administration of a high dose of intravenous NAC seems to be a promising treatment for incipient liver failure in patients with liver disease caused by EPP. (en)